Analysis Date: 2025-12-07T16:58:53.530893 Trading Period: 2025-12-08 to 2025-12-19
Company: CRISPR Therapeutics AG Sector: Healthcare | Industry: Biotechnology Current Price: $56.88 Market Cap: $5,420,677,120 Beta: 1.73 Avg Volume: 2,539,501 Website: https://www.crisprtx.com
Description: CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...
Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio
Rationale: Unfavorable conditions (composite: 38.5/100, risk: EXTREME, red flags: 1).
Passed Filters: ✓ Yes Notes: Passed all screening filters
Composite Score: 3.20/5.0 Percentile Rank: 100%
Factor Scores:
Setup Score: 3/8 Setup Notes: Strong uptrend (above both SMAs); Strong weekly momentum
Price Levels:
Momentum & Volume:
Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 1 Earnings Risk: No
Critical Issues:
This report is generated by PM automated research system. Always perform your own due diligence before trading.